StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Neogenomics (NEO) PT Lowered to $17 at Morgan Stanley
February 19, 2025 8:05 AM
Morgan Stanley analyst Tejas Savant lowered the price target on Neogenomics (NASDAQ: NEO) to $17.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Neogenomics (NEO) PT Lowered to $17 at BTIG
February 19, 2025 2:57 PM
Neogenomics (NEO) PT Lowered to $18 at Jefferies
February 18, 2025 4:19 PM
Form 10-K NEOGENOMICS INC For: Dec 31
February 18, 2025 4:17 PM
Neogenomics (NEO) PT Lowered to $18 at Needham
February 18, 2025 4:01 PM
Raymond James Reiterates Market Perform Rating on Neogenomics (NEO)
February 18, 2025 8:12 AM
Form 8-K NEOGENOMICS INC For: Feb 18
February 18, 2025 7:08 AM
NeoGenomics (NEO) Tops Q4 EPS by 1c; offers guidance
February 18, 2025 7:06 AM
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
February 18, 2025 7:05 AM
